Oct 10, 2021 by Kody KesterThis Dividend Stock Is Unlocking More GrowthThe REIT just entered another major international market.
Oct 9, 2021 by Kody Kester3 Buffett Stocks to Buy Hand Over Fist in OctoberThese three blue-chip stocks are each featured as a top 20 holding of Warren Buffett's Berkshire Hathaway.
Oct 9, 2021 by Kody KesterRegeneron Could Have a Big Catalyst Coming in 2022Cancer drug Libtayo could receive FDA approval for its fourth indication in January.
Oct 7, 2021 by Kody Kester3 Dividend-Paying Nasdaq 100 Stocks to Buy Hand Over Fist in OctoberThese three Nasdaq 100 stocks provide market-beating yields and steady growth potential at attractive valuations.
Oct 5, 2021 by Kody KesterEli Lilly Stock: Buy on the Dip?After a hot start to 2021, the drugmaker's share price has cooled off over the last month.
Oct 5, 2021 by Kody KesterIs Veracyte Still a Buy After Its Recent Rally?Shares of the genetic diagnostics company are down nearly 50% from their 52-week high in February.
Oct 5, 2021 by Kody KesterThis Growth Hormone Drug Could Be a Boost For PfizerPfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January.
Oct 3, 2021 by Kody KesterJohnson & Johnson Sell-Off: Is It a Buying Opportunity?Buying Dividend Kings at fair prices is a one way to achieve strong total returns with lower volatility.
Oct 2, 2021 by Kody KesterBristol Myers Squibb: Should You Buy the Dip?Short-term volatility can be a patient, long-term investor's best friend.
Sep 29, 2021 by Kody KesterThis Potential Indication Could Be a Winner for NovartisThe U.S. Food and Drug Administration accepted Novartis' filing for tislelizumab to treat esophageal cancer.
Sep 29, 2021 by Kody KesterThe Delta Variant Has Made Quest Diagnostics IndispensableOn the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year.
Sep 27, 2021 by Kody KesterCould AbbVie's New Collaboration Be a Blockbuster?AbbVie recently announced a strategic partnership with Regenxbio for wet age-related macular degeneration and diabetic retinopathy treatment.
Sep 27, 2021 by Kody Kester3 Top Biotech Stocks to Buy for the Long HaulEach of these three stocks offers yields that more than double the S&P 500's current yield.
Sep 26, 2021 by Kody KesterIs Now the Time to Buy This Dividend King?Shares of Lowe's are already up 30% year to date, but that doesn't mean this home-improvement retailer has nothing left to offer investors.
Sep 19, 2021 by Kody KesterGot $1,000? Here Are 2 Unstoppable Dividend Stocks to BuyDependable and rationally valued dividend stocks are an income investor's dream.
Sep 18, 2021 by Kody Kester2 Stocks to Buy With Dividends Yielding More Than 4%These two triple-net-lease REITs offer safe and reliable yields to dividend investors at fair valuations.
Sep 17, 2021 by Kody Kester2 Top Healthcare Stocks to Buy Right NowBoth of these stocks are healthcare leaders and they're trading at reasonable valuations.
Sep 16, 2021 by Kody Kester2 Embarrassingly Cheap Dividend Stocks to BuyThe market has written off these two high-quality stocks, but both could complement an income investor's portfolio.
Sep 15, 2021 by Kody Kester2 Best Biotech Stocks to Buy in SeptemberThe market's caution when it comes to the healthcare sector presents a buying opportunity for these two solid businesses.
Sep 14, 2021 by Kody Kester2 Dividend Stocks That Will Pay You for LifeAre you looking for steady dividends to stand the test of time? Here are a couple of stocks to consider buying.
